rs78892693

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_022081.6(HPS4):​c.1883G>A​(p.Arg628His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00048 in 1,614,040 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R628C) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0024 ( 2 hom., cov: 31)
Exomes 𝑓: 0.00028 ( 0 hom. )

Consequence

HPS4
NM_022081.6 missense

Scores

18

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:6

Conservation

PhyloP100: 2.53

Publications

5 publications found
Variant links:
Genes affected
HPS4 (HGNC:15844): (HPS4 biogenesis of lysosomal organelles complex 3 subunit 2) This gene encodes a protein component of biogenesis of lysosome-related organelles complexes (BLOC). BLOC complexes are important for the formation of endosomal-lysosomal organelles such as melanosomes and platelet dense granules. Mutations in this gene result in subtype 4 of Hermansky-Pudlak syndrome, a form of albinism. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2012]
HPS4 Gene-Disease associations (from GenCC):
  • Hermansky-Pudlak syndrome 4
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P, ClinGen
  • Hermansky-Pudlak syndrome with pulmonary fibrosis
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_022081.6, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0057168007).
BP6
Variant 22-26457931-C-T is Benign according to our data. Variant chr22-26457931-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 287655.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00239 (364/152342) while in subpopulation AFR AF = 0.00801 (333/41578). AF 95% confidence interval is 0.0073. There are 2 homozygotes in GnomAd4. There are 175 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 2 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_022081.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
HPS4
NM_022081.6
MANE Select
c.1883G>Ap.Arg628His
missense
Exon 13 of 14NP_071364.4
HPS4
NM_001349900.2
c.1937G>Ap.Arg646His
missense
Exon 14 of 15NP_001336829.1F1LLU8
HPS4
NM_001349901.1
c.1937G>Ap.Arg646His
missense
Exon 14 of 15NP_001336830.1F1LLU8

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
HPS4
ENST00000398145.7
TSL:1 MANE Select
c.1883G>Ap.Arg628His
missense
Exon 13 of 14ENSP00000381213.2Q9NQG7-1
HPS4
ENST00000402105.7
TSL:1
c.1868G>Ap.Arg623His
missense
Exon 11 of 12ENSP00000384185.3Q9NQG7-3
HPS4
ENST00000439453.5
TSL:1
n.*1401G>A
non_coding_transcript_exon
Exon 13 of 14ENSP00000406764.1F8WC53

Frequencies

GnomAD3 genomes
AF:
0.00238
AC:
363
AN:
152224
Hom.:
2
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00801
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00150
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000735
Gnomad OTH
AF:
0.000955
GnomAD2 exomes
AF:
0.000749
AC:
188
AN:
250946
AF XY:
0.000619
show subpopulations
Gnomad AFR exome
AF:
0.00875
Gnomad AMR exome
AF:
0.000694
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000159
Gnomad OTH exome
AF:
0.000163
GnomAD4 exome
AF:
0.000280
AC:
410
AN:
1461698
Hom.:
0
Cov.:
30
AF XY:
0.000279
AC XY:
203
AN XY:
727166
show subpopulations
African (AFR)
AF:
0.00789
AC:
264
AN:
33478
American (AMR)
AF:
0.000626
AC:
28
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.000116
AC:
10
AN:
86256
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53256
Middle Eastern (MID)
AF:
0.000520
AC:
3
AN:
5768
European-Non Finnish (NFE)
AF:
0.0000621
AC:
69
AN:
1111986
Other (OTH)
AF:
0.000596
AC:
36
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.453
Heterozygous variant carriers
0
26
51
77
102
128
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00239
AC:
364
AN:
152342
Hom.:
2
Cov.:
31
AF XY:
0.00235
AC XY:
175
AN XY:
74496
show subpopulations
African (AFR)
AF:
0.00801
AC:
333
AN:
41578
American (AMR)
AF:
0.00150
AC:
23
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5182
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4826
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10624
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000735
AC:
5
AN:
68032
Other (OTH)
AF:
0.000945
AC:
2
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
16
32
48
64
80
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000927
Hom.:
1
Bravo
AF:
0.00259
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.0000545
EpiControl
AF:
0.000178

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
3
not specified (3)
-
-
2
Hermansky-Pudlak syndrome 4 (2)
-
1
-
Inborn genetic diseases (1)
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.089
BayesDel_addAF
Benign
-0.60
T
BayesDel_noAF
Benign
-0.63
CADD
Benign
20
DANN
Benign
0.80
DEOGEN2
Benign
0.092
T
Eigen
Benign
-0.50
Eigen_PC
Benign
-0.37
FATHMM_MKL
Benign
0.48
N
LIST_S2
Benign
0.85
D
MetaRNN
Benign
0.0057
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.83
L
PhyloP100
2.5
PrimateAI
Benign
0.23
T
PROVEAN
Benign
0.33
N
REVEL
Benign
0.024
Sift
Benign
0.36
T
Sift4G
Benign
0.34
T
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.026
gMVP
0.19
Mutation Taster
=92/8
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs78892693;
hg19: chr22-26853897;
COSMIC: COSV61104572;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.